Customer updates during COVID pandemic Click Here >

Leadership Team
Rob Monroe, MD, PhD

Chief Medical Officer

Read bio
Rob Monroe, MD, PhD

Chief Medical Officer

Dr. Rob Monroe brings to ACD a record of success providing medical leadership for both venture-backed and public companies in the clinical diagnostics industry. Most recently, he served as Medical Director and Vice President of Laboratory Operations for Veracyte (VCYT), a diagnostics company focused on molecular cytology, where he led the company’s CLIA laboratories, including oversight of the highly successful Afirma® Thyroid FNA Analysis and recent launch of the Percepta Bronchial Genomic Classifer. Prior to Veracyte, Dr. Monroe served as Chief Medical Officer of BioImagene (acquired by Ventana, a member of the Roche Group, in 2010), a leading provider of imaging solutions for anatomic pathology and clinical diagnostics where he headed the company’s efforts to develop software applications for pathologists, including multiple FDA-cleared algorithms for immunohistochemistry analysis. Dr. Monroe was also Co-Founder and Chief Medical Officer of OncoMDx, a Palo Alto-based molecular diagnostics laboratory later acquired by CORE Diagnostics to support expansion of next generation diagnostics in India.  Prior to joining BioImagene, Dr. Monroe served as a Medical Director for Central Coast Pathology where he led cytopathology and molecular pathology programs.  Dr. Monroe is board certified in anatomic pathology, clinical pathology, and cytopathology.  He holds MD and PhD degrees from Harvard Medical School and completed his pathology training at Stanford and UCLA.

Close
Christopher Bunker, PhD, MBA

VP, Business Development

Read bio
Christopher Bunker, PhD, MBA

VP, Business Development

Dr. Bunker brings ten years of experience in business development with pharmaceutical/biotechnology organizations. Prior to joining ACD, Dr. Bunker was Director of Business Development at Cell Signaling Technology, Inc. (CST), where he helped build the company from its initial spin-out to a $100M business. Before CST, Dr. Bunker pursued cancer research at Genome Therapeutics Corp. Dr. Bunker received a Ph.D in Biological Chemistry from Harvard University and a M.B.A. from the executive program of Boston University. He received post-doctoral training in cancer molecular biology at University of California, San Francisco.

Close
X
Contact Us

Complete one of the three forms below and we will get back to you.

Advanced Cell Diagnostics

Our new headquarters office starting May 2016:

7707 Gateway Blvd.  
Newark, CA 94560
Toll Free: 1 (877) 576-3636
Phone: (510) 576-8800
Fax: (510) 576-8798

 

Bio-Techne

19 Barton Lane  
Abingdon Science Park
Abingdon
OX14 3NB
United Kingdom
Phone 2: +44 1235 529449
Fax: +44 1235 533420

 

 

Advanced Cell Diagnostics China

Building 15, No. 26 Xihuan South Road
Beijing Economic-Technological Development Area
Beijing, China, Zip code: 100176

400-966-1796
info_china.ACD@bio-techne.com
For general information: Leon.Li@bio-techne.com
Web: www.acdbio.com/cn

For general information: Info.ACD@bio-techne.com
For place an order: order.ACD@bio-techne.com
For product support: support.ACD@bio-techne.com
For career opportunities: hr.ACD@bio-techne.com